- June 29, 2009
Sanofi-Aventis's diabetes drug Lantus may increase the risk of cancer, according to European studies involving some 300,000 insulin-treated patients, prompting a call from experts for more research.
[Story at Reuters:
Sanofi drug may increase cancer risk, studies find.
List of studies at
Diabetologia;
commentary by Medical Director of Diabetes Monitor
at
Insulin and cancer.]
- June 22, 2009
A group of international experts from three major medical associations have called for the
A1c
test to be the standard test used to diagnose diabetes.
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes.
Diabetes Care; published ahead of print June 5, 2009, doi:10.2337/dc09-9033
[Story at VOANews.com.
Full text at
Diabetes Care
{PDF file}]
- June 15, 2009
The U.S. Food and Drug Administration has learned that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. have reappeared and are being sold in the U.S. market. Three lots or a total of 129,000 vials of this product were stolen in all. These stolen insulin vials may not have been stored and handled properly and may be dangerous for patients to use.
The FDA has received one report of a patient who suffered an adverse event due to poor control of glucose levels after using a vial from one of these three lots.
[Information from the FDA at FDA Issues Public Health Advisory Regarding Levemir Insulin.
Press release from Novo-Nordisk at
Novo Nordisk Warns Customers About Stolen Insulin.]
- June 8, 2009
The 69th Scientific Sessions of the American Diabetes Association are being held
in New Orleans, Louisiana from June 5 to 9, 2009.
Billed as the world's largest and most prestigious diabetes meeting, the Scientific Sessions provide
cutting-edge education and information for all professional members of the diabetes community.
You can expect numerous news stories about results of clinical trials, and press releases about new products, to
become available during and shortly after this meeting. The Medical Director of this website (WWQ) has an abstract,
Trends in Early Metformin Monotherapy for Newly Diagnosed Type 2 Diabetes in the United States, 2001-2007.
[Information, including abstracts, at 69th Scientific Sessions, at the ADA website.]
- June 1, 2009
A recent study has indicated that over the next decade, the incidence of
type 1 diabetes
among very young children (younger than 5) will double in comparison to the number of cases recorded in 2005 if current trends continue.
Incidence trends for childhood type 1 diabetes in Europe during 1989—2003 and predicted new cases 2005—20: a multicentre prospective registration study.
The Lancet, Early Online Publication, 28 May 2009
doi:10.1016/S0140-6736(09)60568-7.
[Story at HealthNews.
Abstract at
The Lancet;
full text at
The Lancet, requires subscription.]
Advertisement
|
|
|
